ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Down 6.2% – Here’s What Happened

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s share price dropped 6.2% on Friday. The stock traded as low as $20.32 and last traded at $20.50. 105,331 shares traded hands during mid-day trading, a decline of 55% from the average session volume of 233,782 shares. The stock had previously closed at $21.85.

Analyst Ratings Changes

A number of equities analysts have weighed in on CHRN shares. Weiss Ratings upgraded ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 24th. Northland Securities initiated coverage on ChronoScale Corporation Common Stock in a research report on Friday, September 18th. They set an “outperform” rating and a $32.00 price target for the company. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $19.00.

ChronoScale Corporation Common Stock Price Performance

The firm’s 50 day simple moving average is $21.22 and its two-hundred day simple moving average is $17.41. The company has a debt-to-equity ratio of 0.06, a current ratio of 0.51 and a quick ratio of 0.51. The firm has a market capitalization of $2.98 billion, a P/E ratio of -3.80 and a beta of 0.98.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its earnings results on Wednesday, August 19th. The company reported ($0.12) EPS for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The firm had revenue of $18.40 million during the quarter. As a group, analysts predict that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current year.

Hedge Funds Weigh In On ChronoScale Corporation Common Stock

A hedge fund recently raised its position in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc lifted its holdings in ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,338 shares of the company’s stock after buying an additional 1,195 shares during the quarter. Roble Belko & Company Inc owned approximately 0.07% of ChronoScale Corporation Common Stock worth $25,000 as of its most recent SEC filing. 6.42% of the stock is owned by institutional investors and hedge funds.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.